Immunology
3 drugs are in development for Peanut Allergy.
- Companies
- 2
- Clinical trials
- 10
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Peanut Allergy pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
| Drug | Company |
|---|---|
| Viaskin Milk | DBV Technologies S.A. (DBVT) |
| Viaskin Peanut | DBV Technologies S.A. (DBVT) |
BLA Filed(1)
| Drug | Company |
|---|---|
| ar101 | Aimmune Therapeutics, Inc. (AIMT) |
About this indication
Peanut Allergy context
Immunology·MeSH: Peanut Hypersensitivity (D021183)
Also known as: Allergies, Peanut, Hypersensitivity, Groundnut, Hypersensitivity, Peanut
Frequently asked questions
How many drugs are in development for Peanut Allergy?
BioSniper tracks 3 drugs in development for Peanut Allergy across 2 companies.
How many clinical trials target Peanut Allergy?
There are 10 clinical trials targeting Peanut Allergy tracked by BioSniper.